SB 3733 Illinois Senate · 101st Regular Session

INS-GENERIC PRESCRIPTION DRUGS

Summary
Amends the Illinois Insurance Code. Provides that if a generic equivalent for a brand name drug is approved by the Food and Drug Administration, insurance companies with plans that provide coverage for prescription drugs through the use of a drug formulary that are amended, delivered, issued, or renewed in the State on or after January 1, 2021 shall immediately substitute the brand name drug with the generic equivalent or move the brand name drug to a formulary tier that reduces an enrollee's cost. Grants rulemaking authority to the Department of Insurance. Defines "brand name drug", "generic drug", and "formulary". Effective January 1, 2021.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2020
Committee Review
Floor Vote
Governor
Introduced Feb 14, 2020 Last action May 15, 2020
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
17
Key actions
6
Committee
9
May 7, 2020
Upper · Passed
Rule 2-10 Committee Deadline Established As May 22, 2020
upper
Apr 30, 2020
Upper · Passed
Rule 2-10 Committee Deadline Established As May 15, 2020
upper
Apr 23, 2020
Upper · Passed
Rule 2-10 Committee Deadline Established As May 7, 2020
upper
Apr 16, 2020
Upper · Passed
Rule 2-10 Committee Deadline Established As April 30, 2020
upper
Apr 12, 2020
Committee
Pursuant to Senate Rule 3-9(b) / Referred to Assignments
upper
Mar 25, 2020
Upper · Passed
Rule 2-10 Committee Deadline Established As April 24, 2020
upper
Mar 18, 2020
Upper · Passed
Rule 2-10 Committee Deadline Established As April 2, 2020
upper
Mar 3, 2020
Committee
Assigned to Insurance
upper
Feb 14, 2020
Committee
Referred to Assignments
upper
0 primary · 2 co-sponsors

Sponsors

No sponsor information available.